Literature DB >> 33554502

Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study.

Anna Schaffner1, Lorenz Risch2,3, Myriam Weber1, Sarah Thiel1, Katharina Jüngert1, Michael Pichler1, Nadia Wohlwend3, Thomas Lung3, Michael Ritzler3, Dorothea Hillmann3, Sandra Copeland1, Harald Renz4, Matthias Paprotny1, Martin Risch5.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody; coronavirus; kinetics

Year:  2020        PMID： 33554502     DOI： 10.1515/cclm-2020-1347

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  7 in total

1.  Prevalence of SARS-CoV-2 antibodies and risk factors in the pandemic epicentre of Catalonia.

Authors:  Sandra Moreno; Queralt Miró; Ainhoa Soler; Mireia Gallego; Maria Homs; Maria José Garcia
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

2.  IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers.

Authors:  Giulia Brisotto; Elena Muraro; Marcella Montico; Chiara Corso; Chiara Evangelista; Mariateresa Casarotto; Cristina Caffau; Roberto Vettori; Maria Rita Cozzi; Stefania Zanussi; Matteo Turetta; Federico Ronchese; Agostino Steffan
Journal:  Clin Chim Acta       Date:  2021-10-29       Impact factor: 3.786

3.  Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future.

Authors:  Fausto Baldanti; Nirmal K Ganguly; Guiqiang Wang; Martin Möckel; Luke A O'Neill; Harald Renz; Carlos Eduardo Dos Santos Ferreira; Kazuhiro Tateda; Barbara Van Der Pol
Journal:  Crit Rev Clin Lab Sci       Date:  2022-03-15       Impact factor: 6.250

4.  Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria.

Authors:  Heike Rebholz; Ralf J Braun; Titas Saha; Oliver Harzer; Miriam Schneider; Dennis Ladage
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

Review 5.  Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review.

Authors:  Irina Arkhipova-Jenkins; Mark Helfand; Charlotte Armstrong; Emily Gean; Joanna Anderson; Robin A Paynter; Katherine Mackey
Journal:  Ann Intern Med       Date:  2021-03-16       Impact factor: 25.391

6.  What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).

Authors:  Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; Mary Ann Forciea; George M Abraham; Matthew C Miller; Adam J Obley; Linda L Humphrey; Robert M Centor; Elie A Akl; Rebecca Andrews; Thomas A Bledsoe; Ray Haeme; Devan L Kansagara
Journal:  Ann Intern Med       Date:  2021-03-16       Impact factor: 25.391

7.  Persistence of humoral response upon SARS-CoV-2 infection.

Authors:  Andrea Knies; Dennis Ladage; Ralf J Braun; Janine Kimpel; Miriam Schneider
Journal:  Rev Med Virol       Date:  2021-06-30       Impact factor: 11.043
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.